An interventional study of Enhanced Recovery After Surgery (ERAS) Early Mobilization Protocol in Gastrointestinal Diseases, sponsored by Uludag University. Enrolling by invitation at 1 site in Turkey. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-11-13.
Sponsored by Uludag University · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Gastrointestinal Diseases with a site in Turkey — 3 open to participants now, 4 under way, none of them phase 3. Gastrointestinal Diseases · Turkey.
Among the 11 studies in Gastrointestinal Diseases with a site in Turkey, this one is one of 2 that started in 2024, is one of 6 with no phase, and was the 8th registered.
549 studies on the registry are indexed under Gastrointestinal Diseases; 102 are open to participants now.
Browse Gastrointestinal Diseases studies →3 of the 11 studies in Gastrointestinal Diseases with a site in Turkey are open now. Recruiting first, the newest first:
Ardahan University · Sites in Turkey
Ages 18+
Ozkul Yilmaz Colak · Sites in Turkey
Ages 18+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 66 Gastrointestinal Diseases studies recruiting now, 30 (45%) set no upper age limit and 23 (35%) stop at 75 or younger; 19 take children under 18; 21 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 2 · Phase 3 2
First in 2001; this study’s year is marked. 2 started in 2024.
This study's planned enrollment of 100 is above the median of 80 across 388 interventional studies indexed under Gastrointestinal Diseases.
Median enrollment 60 across the 9 interventional studies, 1,650 across the 2 observational. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 11 have an industry lead sponsor. The 10 most frequent:
Uludag University is the lead sponsor of 149 studies on the registry; 41 are open to participants now.
Uludag University has 1 study filed under Gastrointestinal Diseases — fewer than ten, so there is no comparison to draw.
2 of the studies in Gastrointestinal Diseases with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07586254Ozkul Yilmaz ColakAdding a Gastrointestinal Subscore to SOFA2 for Mortality Risk Assessment in the ICU: The SOFA2-GIS Study | 2026-12 |
| NCT07745959Ardahan UniversityEffect of Virtual Reality Before Upper Gastrointestinal Endoscopy on Preprocedural Anxiety, Psychological Readiness, and Postprocedural Satisfaction | 2027-02-28 |
Add all 2 to your calendar (.ics) → With an account.
Among the 11 studies in Gastrointestinal Diseases with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
In this study, the investigators aimed to evaluate the early mobilization protocol created in accordance with the accelerated recovery guide after surgery in patients undergoing gastrointestinal surgery.
This study is an experimental study. The participants in the control group are applied to the mobilization applied in routine clinics. The participants in the intervention group are applied to the mobilization protocol created in accordance with the Enhanced Recovery After Surgery (ERAS) guidelines. It is planned to evaluate the postoperative mobilization process of both groups.
In this study, the researchers aimed to evaluate the early mobilization protocol created in accordance with the accelerated recovery guide after surgery in patients undergoing gastrointestinal surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants undergoing gastrointestinal surgery will receive routine clinic mobilization. The investigator will not perform any interventions.
Participants undergoing gastrointestinal surgery will watch a video 1 day before surgery that includes information about the importance of mobilization and the process. The participant will be applied a mobilization protocol created in line with the postoperative mobilization eras (enhanced recovery after surgery) guidelines.
Procedure: Enhanced Recovery After Surgery (ERAS) Early Mobilization Protocol
The intervention is applied from the first day after surgery until discharge. (including the day of discharge).
Also known as: Early Mobilization Protocol
The effect of the ERAS (Enhanced Recovery After Surgery) early mobilization protocol on the number of steps taken daily after surgery
The number of steps taken by the participant daily after surgery will be measured via a phone pedometer application (StepsApp).
Time frame: From admission to discharge, up to 1 week
The effect of the ERAS (Enhanced Recovery After Surgery) early mobilization protocol on the distance moved after surgery
The daily distance moved by the participant after surgery will be measured via a phone pedometer application (StepsApp).
Time frame: From admission to discharge, up to 1 week
The effect of the ERAS early mobilization protocol on the recovery of the gastrointestinal system after surgery
The researcher will record the day the participant first passed gas after surgery and the date of his/her first defecation.
Time frame: From admission to discharge, up to 1 week
The effect of the ERAS (Enhanced Recovery After Surgery) early mobilization protocol on the level of ability to perform daily living activities after surgery
The researcher makes the measurement with the Modified Barthel Index scale. Modified Barthel Index: The highest score is 100, the lowest score is 0. The patient is stated as fully dependent in the range of 0-20 points, highly dependent in the range of 21-61 points, moderately dependent in the range of 62-90 points, slightly dependent in the range of 91-99 points, and fully independent in the range of 100 points. Daily evaluations are made until discharge after surgery.
Time frame: (From admission to discharge, up to 1 week) and (When he comes for a check-up 1 week after discharge)
Plan to share: No
No publications or documents are linked to this record.
Started Nov 2024 (actual). Primary completion is estimated for Nov 2025, 11 months after the start.
Of 127 non-industry interventional studies with no phase under Gastrointestinal Diseases, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 46. This study's planned 11 months is below that.
Counting every sponsor, half of 149 studies reached it within 24 months; a quarter within 10 and three quarters within 45.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.